Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
- PMID: 36762989
- PMCID: PMC9930779
- DOI: 10.1080/0886022X.2022.2146512
Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
Abstract
Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) via the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.
Keywords: Diabetic kidney disease (DKD); oxidative stress; pathogenesis; traditional Chinese medicine.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
Traditional Chinese Medicine Formulae and Chinese Patent Medicines for the Treatment of Diabetic Kidney Disease: Efficacies and Mechanisms.Am J Chin Med. 2025;53(3):675-707. doi: 10.1142/S0192415X25500260. Am J Chin Med. 2025. PMID: 40374376 Review.
-
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease.Antioxidants (Basel). 2024 Apr 12;13(4):455. doi: 10.3390/antiox13040455. Antioxidants (Basel). 2024. PMID: 38671903 Free PMC article. Review.
-
mTOR-mediated nutrient sensing and oxidative stress pathways regulate autophagy: a key mechanism for traditional Chinese medicine to improve diabetic kidney disease.Front Pharmacol. 2025 Apr 23;16:1578400. doi: 10.3389/fphar.2025.1578400. eCollection 2025. Front Pharmacol. 2025. PMID: 40337513 Free PMC article. Review.
-
Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment.Pharm Biol. 2024 Dec;62(1):222-232. doi: 10.1080/13880209.2024.2314705. Epub 2024 Feb 15. Pharm Biol. 2024. PMID: 38357845 Free PMC article. Review.
-
Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.J Ethnopharmacol. 2022 Jul 15;293:115246. doi: 10.1016/j.jep.2022.115246. Epub 2022 Apr 7. J Ethnopharmacol. 2022. PMID: 35398500
Cited by
-
Preventive treatment of tripdiolide ameliorates kidney injury in diabetic mice by modulating the Nrf2/NF-κB pathway.Front Pharmacol. 2025 Mar 19;16:1492834. doi: 10.3389/fphar.2025.1492834. eCollection 2025. Front Pharmacol. 2025. PMID: 40176887 Free PMC article.
-
Integrated UPLC-ESI-MS/MS, network pharmacology, and transcriptomics to reveal the material basis and mechanism of Schisandra chinensis Fruit Mixture against diabetic nephropathy.Front Immunol. 2025 Feb 19;15:1526465. doi: 10.3389/fimmu.2024.1526465. eCollection 2024. Front Immunol. 2025. PMID: 40046619 Free PMC article.
-
Empagliflozin alleviates type 2 diabetic renal fibrosis by inhibiting SLC7A7-mediated ferroptosis.Diabetol Metab Syndr. 2025 Aug 13;17(1):329. doi: 10.1186/s13098-025-01902-6. Diabetol Metab Syndr. 2025. PMID: 40804641 Free PMC article.
-
Advances of Iron and Ferroptosis in Diabetic Kidney Disease.Kidney Int Rep. 2024 Apr 3;9(7):1972-1985. doi: 10.1016/j.ekir.2024.04.012. eCollection 2024 Jul. Kidney Int Rep. 2024. PMID: 39081773 Free PMC article. Review.
-
Empagliflozin's role in early tubular protection for type 2 diabetes patients.Mol Med. 2024 Jul 31;30(1):112. doi: 10.1186/s10020-024-00881-0. Mol Med. 2024. PMID: 39085830 Free PMC article. Clinical Trial.
References
-
- Federation ID . IDF Diabetes Atlas. 2021.
-
- Kao MPC, Ang DSC, Pall A, et al. . Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J Hum Hypertens. 2010;24(1):1–8. - PubMed
-
- Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5(5):561–568. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical